# FDA Inspection 1202009 - Glynis Ablon, M.D. - March 24, 2023

Source: https://www.keypedia.com/records/fda_inspections/glynis-ablon-md/8c4a0d25-3016-42c8-b1aa-f01343ef025e
Source feed: FDA_Inspections

> FDA Inspection 1202009 for Glynis Ablon, M.D. on March 24, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202009
- Company Name: Glynis Ablon, M.D.
- Inspection Date: 2023-03-24
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/glynis-ablon-md/23601447-d419-4a1f-bed0-a6c22dfcdaaa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c